Spotting A Winner: NRX Pharmaceuticals Inc (NASDAQ: NRXP) Retreats -11.96 And It Still Have Room To Run

NRX Pharmaceuticals Inc (NASDAQ:NRXP) currently has a daily average trading volume of 1.01M but it saw 1185925 shares traded in last market. With a market cap of 54.30M USD, the company’s current market price of $4.49 came falling about -11.96 while comparing to the previous closing price of $5.10. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.33 and as low as $1.10. In the recent trading on the day, stock has struck highest price mark of $4.08 while lowest mark touched by it was $5.01.

Taking a look at 20-day trading activity of NRX Pharmaceuticals Inc (NRXP) gives us an average price of $2.71, while its current price level is -38.77% below from 52-week high level whereas it is 308.18% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.84 while that of 200 days or SMA-200 reads an average of $2.38. A closer look into the stock’s movement over the week reveals that its volatility is standing at 31.41% during that period while stretching the period over a month that decreases to 28.08%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 68.05 which implies that the stock is in neutral territory.

Over the week, NRXP’s stock price is moving -3.65% down while it is 274.17% when we observe its performance for the past one month. Year-to-date it is 104.09% up and over the past year, the stock is showing an upside performance of 4.93%.

The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.29 while estimate for next year EPS is -1.86.

Currently, NRX Pharmaceuticals Inc’s total number of outstanding shares is 11.37M with 23.56% of that held by the insiders while 6.05% of its common stock has been owned by the institutions. It has a 14.03 of forward P/E ratio. Stock’s beta reads 0.94. Its return on asset (ROA) is -231.96% on average.